Colgate-Palmolive Company (CL)
Take the Zacks Approach to Beat the Markets: Intellia, Colgate-Palmolive, Getty in Focus
NTLA, CL and GTY are in focus as Zacks highlights strong 12-week gains and post-upgrade rallies across its Focus List and model portfolios.
Is Colgate's Supply-Chain Resilience Providing Competitive Edge?
CL leans on supply-chain resilience after a volatile 2025, delivering record sales and eyeing margin expansion in 2026.
Colgate-Palmolive (CL) is a Top-Ranked Growth Stock: Should You Buy?
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Pricing vs. Volume: Can Colgate Balance Growth in a Soft Market?
CL faces muted demand and cautious consumers as it balances pricing discipline with volume recovery to protect growth in a soft global market.
Colgate-Palmolive Dividend Scorecard: How Does the 2.6% Yield Stack Up?
Colgate-Palmolive just sent $0.52 per share to investors that will land on February 13, 2026, marking another quarterly payment in the consumer goods giant's 63-year dividend increase streak.
Colgate-Palmolive: Still A Buy As The 2030 Growth Strategy Begins
Colgate-Palmolive remains a Buy as it enters its next 5-year plan, leveraging strong brands and resilient financials. Q4 earnings beat expectations, with record cash flow from operations and robust performance in emerging markets driving a 5.9% revenue increase. Guidance reflects uncertainty, projecting 2–6% net sales growth and 1–4% organic sales growth, while CL advances its $5B buyback and maintains a solid payout.
Why Colgate-Palmolive (CL) is a Top Momentum Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Here's Why Colgate-Palmolive (CL) is a Strong Growth Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Colgate-Palmolive Company (CL) Q4 2025 Earnings Call Transcript
Colgate-Palmolive Company (CL) Q4 2025 Earnings Call Transcript
Colgate Q4 Earnings Top Estimates, Strong Pricing Drives Results
CL's Q4 earnings beat estimates as strong pricing and brand leadership lifted sales, with solid gains in Latin America and resilient global demand.
Colgate-Palmolive (CL) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
Although the revenue and EPS for Colgate-Palmolive (CL) give a sense of how its business performed in the quarter ended December 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Colgate-Palmolive (CL) Q4 Earnings and Revenues Surpass Estimates
Colgate-Palmolive (CL) came out with quarterly earnings of $0.95 per share, beating the Zacks Consensus Estimate of $0.91 per share. This compares to earnings of $0.91 per share a year ago.
